Avenue stock
News, US Markets

Avenue Therapeutics (NASDAQ: ATXI) Stock Skyrockets on Positive FDA Developments for IV Tramadol

/

On Thursday, Avenue Therapeutics (NASDAQ: ATXI) stock surged by almost 96% after the specialty pharmaceutical company secured final approval from […]

Avenue Therapeutics (NASDAQ: ATXI) Stock Skyrockets on Positive FDA Developments for IV Tramadol Read More »